anidulafungin has been researched along with Morbid Obesity in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Davis, SL; Hutton, M; Kenney, RM; Vazquez, JA | 1 |
| Brüggemann, RJ; Burger, DM; Knibbe, CA; Lempers, VJ; Ter Heine, R; van Dongen, EP; Wasmann, RE | 1 |
| Aarnoutse, RE; Brüggemann, RJ; Burger, DM; Knibbe, CA; Lempers, VJ; van Dongen, EP; van Ramshorst, B; van Rongen, A | 1 |
1 trial(s) available for anidulafungin and Morbid Obesity
| Article | Year |
|---|---|
Does Weight Impact Anidulafungin Pharmacokinetics?
Topics: Adult; Aged; Anidulafungin; Antifungal Agents; Area Under Curve; Body Mass Index; Echinocandins; Female; Humans; Male; Metabolic Clearance Rate; Middle Aged; Obesity, Morbid | 2016 |
2 other study(ies) available for anidulafungin and Morbid Obesity
| Article | Year |
|---|---|
Influence of Body Weight Category on Outcomes in Candidemia Patients Treated With Anidulafungin.
Topics: Anidulafungin; Antifungal Agents; Candida; Candidemia; Humans; Obesity, Morbid; Retrospective Studies | 2022 |
Pharmacokinetics of Anidulafungin in Obese and Normal-Weight Adults.
Topics: Adult; Aged; Anidulafungin; Antifungal Agents; Body Weight; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Obesity, Morbid; Young Adult | 2018 |